ArticleFrontiers in pharmacology2022

Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury.

Wenli Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.